Showing results 35 to 54 of 102
< previous
next >
| Issue Date | Title | Author(s) |
| 2021-01-19 | Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. | Jha, NK; Ojha, S; Jha, SK; Dureja, H; Singh, SK; Shukla, SD; Chellappan, DK; Gupta, G; Bhardwaj, S; Kumar, N; Jeyaraman, M; Jain, R; Muthu, S; Kar, R; Kumar, D; Goswami, VK; Ruokolainen, J; Kesari, KK; Singh, SK; Dua, K |
| - | Expanding arsenal against diabetes mellitus through nanoformulations loaded with glimepiride and simvastatin: A comparative study | Pandey, NK; Singh, SK; Kumar, B; Gulati, M; Vishwas, S; Khursheed, R; Dureja, H; Chellappan, DK; Jha, NK; Sharma, A; Jha, SK; Gupta, PK; Gupta, S; Gupta, G; Prasher, P; Dua, K |
| - | Expanding the arsenal against pulmonary diseases using surface-functionalized polymeric micelles: breakthroughs and bottlenecks | Khursheed, R; Paudel, KR; Gulati, M; Vishwas, S; Jha, NK; Hansbro, PM; Oliver, BG; Dua, K; Singh, SK |
| 2021-05-17 | Exploring role of polysaccharides present in Ganoderma lucidium extract powder and probiotics as solid carriers in development of liquisolid formulation loaded with quercetin: A novel study. | Khursheed, R; Singh, SK; Gulati, M; Wadhwa, S; Kapoor, B; Pandey, NK; Chellappan, DK; Gupta, G; Jha, NK; Dua, K; Kapoor, DN; Karri, VVSR; Pattanayak, P; Sharni, A; Mondal, S |
| 2023-03-28 | Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases. | Maurya, S; Srivastava, R; Arfin, S; Hawthorne, S; Jha, NK; Agrawal, K; Raj, S; Rathi, B; Kumar, A; Raj, R; Agrawal, S; Paiva-Santos, AC; Malik, AA; Dua, K; Rana, R; Ojha, S; Jha, SK; Sharma, A; Kumar, D; El-Zahaby, SA; Nagar, A |
| 2022-01-01 | Exploring the mechanistic perspective of a new anti-tumor agent: Melatonin | Rohilla, S; Singh, M; Priya, S; Almalki, WH; Haniffa, SM; Subramaniyan, V; Fuloria, S; Fuloria, NK; Sekar, M; Singh, SK; Jha, NK; Chellappan, DK; Negi, P; Dua, K; Gupta, G |
| - | Exploring the role of antibiotics and steroids in managing respiratory diseases | Chellappan, DK; Prasher, P; Shukla, SD; Yee, TW; Kah, TK; Xyan, TW; Kid, TW; Si, TH; Weng, TS; Molugulu, N; Sakthivel, LP; Chellian, J; Madheswaran, T; Malipeddi, H; Singh, Y; Dureja, H; Kapoor, DN; Negi, P; Goyal, R; Thangavelu, L; Kumar, D; Gupta, PK; Jha, NK; Shastri, MD; MacLoughlin, R; Singh, SK; Gulati, M; Gupta, G; Dua, K |
| 2021-01 | Female gender as a risk factor for developing COPD. | Shukla, SD; Shastri, MD; Jha, NK; Gupta, G; Chellappan, DK; Bagade, T; Dua, K |
| 2022-02 | Harnessing the therapeutic potential of fisetin and its nanoparticles: Journey so far and road ahead | Vishwas, S; Singh, SK; Gulati, M; Awasthi, A; Khursheed, R; Corrie, L; Kumar, R; Collet, T; Loebenberg, R; Porwal, O; Gupta, S; Jha, NK; Gupta, PK; Devkota, HP; Chellappan, DK; Gupta, G; Adams, J; Dua, K |
| 2021 | Immunotherapy for Alzheimer's Disease: Current Scenario and Future Perspectives. | Usman, MB; Bhardwaj, S; Roychoudhury, S; Kumar, D; Alexiou, A; Kumar, P; Ambasta, RK; Prasher, P; Shukla, S; Upadhye, V; Khan, FA; Awasthi, R; Shastri, MD; Singh, SK; Gupta, G; Chellappan, DK; Dua, K; Jha, SK; Ruokolainen, J; Kesari, KK; Ojha, S; Jha, NK |
| 2021-11 | Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges | Kumbhar, P; Manjappa, A; Shah, R; Jha, NK; Singh, SK; Dua, K; Disouza, J; Patravale, V |
| 2021-08 | Interleukin-13: A pivotal target against influenza-induced exacerbation of chronic lung diseases | Shastri, MD; Allam, VSRR; Shukla, SD; Jha, NK; Paudel, KR; Peterson, GM; Patel, RP; Hansbro, PM; Chellappan, DK; Dua, K |
| 2022-02 | Journey of Alpinia galanga from kitchen spice to nutraceutical to folk medicine to nanomedicine | Ramanunny, AK; Wadhwa, S; Gulati, M; Vishwas, S; Khursheed, R; Paudel, KR; Gupta, S; Porwal, O; Alshahrani, SM; Jha, NK; Chellappan, DK; Prasher, P; Gupta, G; Adams, J; Dua, K; Tewary, D; Singh, SK |
| 2020-01 | Microbial determinants of arthritis. | Shukla, SD; Shastri, MD; Jha, NK; Dua, K |
| 2022 | Microbiome in Idiopathic Pulmonary Fibrosis | Pathak, S; Mishra, A; Gupta, G; Raizaday, A; Singh, SK; Kumar, P; Singh, SK; Jha, NK; Chellappan, DK; Dua, K |
| 2021-12 | Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives | Pattanayak, P; Singh, SK; Gulati, M; Vishwas, S; Kapoor, B; Chellappan, DK; Anand, K; Gupta, G; Jha, NK; Gupta, PK; Prasher, P; Dua, K; Dureja, H; Kumar, D; Kumar, V |
| 2021-07 | Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies | Alnuqaydan, AM; Almutary, AG; Sukamaran, A; Yang, BTW; Lee, XT; Lim, WX; Ng, YM; Ibrahim, R; Darmarajan, T; Nanjappan, S; Chellian, J; Candasamy, M; Madheswaran, T; Sharma, A; Dureja, H; Prasher, P; Verma, N; Kumar, D; Palaniveloo, K; Bisht, D; Gupta, G; Madan, JR; Singh, SK; Jha, NK; Dua, K; Chellappan, DK |
| - | Mitigating inflammation using advanced drug delivery by targeting TNF-α in lung diseases | Das, SS; Singh, SK; Verma, PRP; Jha, NK; Gupta, PK; Dua, K |
| - | Mitochondrial dysfunctions associated with chronic respiratory diseases and their targeted therapies: an update | Chellappan, DK; Dharwal, V; Paudel, KR; Jha, NK; MacLoughlin, R; Oliver, BG; M Hansbro, P; Dua, K |
| 2022-03 | Molecular mechanisms of developmental pathways in neurological disorders: a pharmacological and therapeutic review | Jha, NK; Chen, W-C; Kumar, S; Dubey, R; Tsai, L-W; Kar, R; Jha, SK; Gupta, PK; Sharma, A; Gundamaraju, R; Pant, K; Mani, S; Singh, SK; Maccioni, RB; Datta, T; Singh, SK; Gupta, G; Prasher, P; Dua, K; Dey, A; Sharma, C; Mughal, YH; Ruokolainen, J; Kesari, KK; Ojha, S |
